Please login to the form below

Not currently logged in
Email:
Password:

Herpes

This page shows the latest Herpes news and features for those working in and with pharma, biotech and healthcare.

Shire’s Maribavir wins US breakthrough therapy designation

Shire’s Maribavir wins US breakthrough therapy designation

The infection - categorised as a beta herpes virus - can cause clinically challenging complications, which can be fatal in patients with compromised immunity.

Latest news

More from news
Approximately 6 fully matching, plus 41 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    contain the adjuvant QS-21 Stimulon.  In October 2017 GSK's QS-21 Stimulon herpes zoster vaccine, Shingrix, was approved by the FDA.  GSK's malarial vaccine, Mosquirix which also contains

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    10. ‡‡BioAlliance Pharma/ Innocutis. Licence. Sitavig (acyclovir Lauriad) for recurrent herpes labialis (approved).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics